Wells Fargo & Company MN Purchases 2,784 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Wells Fargo & Company MN boosted its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 25.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,543 shares of the medical instruments supplier's stock after buying an additional 2,784 shares during the quarter. Wells Fargo & Company MN owned approximately 0.06% of ICU Medical worth $2,101,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Harvest Fund Management Co. Ltd bought a new position in shares of ICU Medical in the 4th quarter worth about $33,000. Murphy & Mullick Capital Management Corp bought a new stake in ICU Medical in the 4th quarter valued at about $52,000. Venturi Wealth Management LLC increased its position in ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after buying an additional 206 shares in the last quarter. Smartleaf Asset Management LLC increased its position in ICU Medical by 166.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after buying an additional 567 shares in the last quarter. Finally, Huntington National Bank increased its position in ICU Medical by 6.2% in the 4th quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock valued at $218,000 after buying an additional 82 shares in the last quarter. 96.10% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. KeyCorp decreased their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research note on Wednesday, March 12th. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $162.67.

ICU Medical Trading Up 0.2 %

NASDAQ:ICUI traded up $0.24 during trading hours on Monday, reaching $135.90. The company's stock had a trading volume of 297,693 shares, compared to its average volume of 274,101. The firm has a market capitalization of $3.34 billion, a price-to-earnings ratio of -29.74 and a beta of 0.86. The firm has a 50-day simple moving average of $143.25 and a 200-day simple moving average of $157.64. ICU Medical, Inc. has a 1 year low of $95.44 and a 1 year high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.